Physician profile
Scott Martin
NPI 1366762676
$2,932.49
in general payments reported to CMS, 2019-2025
19 companies · $829 in 2025
The $829 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $376 · 2022: $269 · 2023: $616 · 2024: $842 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,286.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $856.33 | 2021-2025 | Evenity, Prolia, Krystexxa |
| Radius Health, INC. | $711.45 | 2023-2025 | Tymlos |
| Valinor Pharma, LLC | $390.97 | 2024-2025 | Movantik |
| Stryker Corporation | $157.83 | 2022-2025 | Variax, Hydroset |
| Azurity Pharmaceuticals, INC. | $106.96 | 2023-2024 | Horizant, Horizant |
| Pacira Pharmaceuticals Incorporated | $87.11 | 2021-2025 | Zilretta, Exparel, Iovera |
| Fidia Pharma USA INC. | $85.12 | 2021 | |
| Virtus Pharmaceuticals LLC | $84.33 | 2024-2025 | Levorphanol Tartrate |
| Arbor Pharmaceuticals, INC. | $83.03 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $75.17 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $68.80 | 2024-2025 | |
| Dynasplint Systems INC. | $45.93 | 2025 | Dynasplint |
| Sanofi-Aventis U.S. LLC | $37.82 | 2021-2022 | |
| Bioventus LLC | $36.74 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.85 | 2024-2025 | Relistor |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $22.71 | 2023 | Arista Ah Flexitip |
| Forte Bio-Pharma LLC | $20.24 | 2025 | Prolate, Tanlor, Nalocet |
| Sanofi Pasteur INC. | $17.66 | 2024 | |
| Avanos Medical | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.